Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5142687 | 0.89 | GAA (0.77) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL21765844 | 0.88 | POLB (0.56) | GAAALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL28627031 | 0.85 | GAA (0.72) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL28712302 | 0.84 | GAA (0.70) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL29678198 | 0.84 | GAA (0.70) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL15145824 | 0.84 | GAA (0.70) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL5690831 | 0.84 | GAA (1.00) | GAAALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL27641820 | 0.84 | GAA (0.70) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL29388992 | 0.84 | GAA (0.70) | GAAALDH1A1HPGDSMN1; SMN2MAOA | |
| SCHEMBL4011436 | 0.84 | GAA (0.70) | GAAALDH1A1HPGDSMN1; SMN2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716344-B | 2- ((2-acetamidophenyl) amino) acetamido compound and preparation method and application thereof | 湖南科技大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-114716344-A | 2- ((2-acetamidophenyl) amino) acetyl arylamine compound and preparation method and application thereof | 湖南科技大学 | 2022-07-08 | — | — | CN | disclosed |
| CN-113292523-A | Selective butyrylcholine esterase inhibitor or medicinal salt thereof, and preparation method and application thereof | 中国药科大学 | 2021-08-24 | — | — | CN | disclosed |
| US-8758935-B2 | Soluble polymer with multi-stable electric states and products comprising such polymer | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-06-24 | — | — | US | disclosed |
| US-20110294976-A1 | SOLUBLE POLYMER WITH MULTI-STABLE ELECTRIC STATES AND PRODUCTS COMPRISING SUCH POLYMER | National University of Singpore (SG) | 2011-12-01 | — | — | US | disclosed |
| WO-2010090603-A1 | SOLUBLE POLYMER WITH MULTI-STABLE ELECTRIC STATES AND PRODUCTS COMPRISING SUCH POLYMER | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2010-08-12 | — | — | WO | disclosed |
| EP-1542869-A2 | MOLECULAR SCALE ELECTRONIC DEVICES | Yale University (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1542869-A4 | MOLECULAR SCALE ELECTRONIC DEVICES | UNIV YALE (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20050101063-A1 | Three-terminal field-controlled molecular devices | TOUR JAMES M (US) | 2005-05-12 | — | — | US | disclosed |
| EP-0950669-B1 | Method of catalytic crosslinking of polymers and two-pack composition used therein | ROHM & HAAS (US) | 2004-09-08 | — | — | EP | disclosed |
| US-6306991-B1 | TWO PART COATING COMPOSITION WITH TWO CONTAINERS, OXIDATIVE POLYMERS WITH CROSSLINKABLE FUNCTIONAL GROUPS | ROHM AND HAAS COMPANY | 2001-10-23 | — | — | US | disclosed |
| WO-2001027972-A2 | MOLECULAR SCALE ELECTRONIC DEVICES | YALE UNIVERSITY (US) | 2001-04-19 | — | — | WO | disclosed |
| US-6149977-A | CONTACTING THE OXIDATIVE POLYMER WITH A CATALYTIC AMOUNT OF AN OXIDIZING ENZYME, SUCH AS HORSERADISH PEROXIDASE. | ROHM AND HAAS COMPANY (US) | 2000-11-21 | — | — | US | disclosed |
| EP-0950669-A2 | Method of catalytic crosslinking of polymers and two-pack composition used therein | ROHM AND HAAS COMPANY (US) | 1999-10-20 | — | — | EP | disclosed |
| EP-0222576-B1 | HETEROCYCLIC OXOPHTHALAZINYL ACETIC ACIDS | PFIZER INC. (US) | 1992-03-18 | — | — | EP | disclosed |
| US-4939140-A | ALDOSE REDUCTASE INHIBITORS | PFIZER INC. (US) | 1990-07-03 | — | — | US | disclosed |
| EP-0222576-A2 | Heterocyclic oxophthalazinyl acetic acids | PFIZER INC. (US) | 1987-05-20 | — | — | EP | disclosed |
| EP-0023557-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED NITROARYL COMPOUNDS | CIBA-GEIGY AG (CH) | 1984-08-01 | — | — | EP | disclosed |
| US-4339618-A | Process for the production of substituted nitroaryl compounds | CIBA-GEIGY AG (CH) | 1982-07-13 | — | — | US | disclosed |
| EP-0023557-A1 | Process for the preparation of substituted nitroaryl compounds | CIBA-GEIGY AG (CH) | 1981-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294976-A1 | SOLUBLE POLYMER WITH MULTI-STABLE ELECTRIC STATES AND PRODUCTS COMPRISING SUCH POLYMER | EPCAM, CD44, DCX | GAA 3911/4885ALDH1A1 2819/4885HPGD 3897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.